Warburton Technology Ltd.

Warburton Technology Ltd. focuses on advanced animal health solutions, particularly enhancing cattle health and productivity through innovative products designed for beef and dairy production. Founded in 2001 in Ireland, Warburton Technology Ltd. operates primarily in the animal health sector, providing specialized products to cattle producers and dairy farmers.

The company has engaged in a strategic investment deal in December 2019 with Paine Schwartz Partners and Rabo Investments, aimed at bolstering its capabilities in animal health and nutrition. The firm has successfully completed one deal to date, marking its commitment to growth in the industry. The company offers Axiota® Global Gateway, which includes products like Multimin® 90, a trace mineral injection supplying essential nutrients to cattle, and Lactipro®, a probiotic that improves rumen health. These products are distributed to cattle ranchers and dairy operators to enhance livestock health and manage production risks across regions such as the United States, Mexico, Brazil, and the European Union.

In 2021, Warburton Technology Ltd. reported a revenue of USD 12. 08 mn and an EBITDA of USD 944,214. 7, generated through direct sales of its core products to agricultural producers and distributors, emphasizing a B2B sales model.

The company plans to leverage the investment from December 2019 to establish a comprehensive Animal Health & Nutrition platform. Future initiatives include the development of new products aimed at enhancing livestock health, alongside an expansion into new markets, targeting regions with growing agricultural sectors. Specific geographic expansions and product launches are in preparation but details regarding release dates are yet to be disclosed.